Sphingosine 1-phosphate (S1P) is a ligand for S1P family receptors (S1P 1 -S1P 5 ).
Introduction
As an extracellular signaling molecule, sphingosine 1-phosphate (S1P) affects several cellular processes including proliferation, migration, differentiation, actin cytoskeleton reorganization, and adherens junction assembly [1] . Through these cellular responses, S1P plays important functions in the vascular and immune systems. S1P is a ligand for S1P/Edg family receptors, which are seven-span membrane proteins coupled to heterotrimeric G proteins. To date, five members of this family have been identified in mammals, S1P 1 /Edg1, S1P 2 /Edg5/H218, S1P 3 /Edg3, S1P 4 /Edg6, and S1P 5 /Edg8 [2] [3] [4] [5] .
Of the five, S1P 1 is arguably the most important, since only disruption of the S1P 1 gene causes embryonic lethality, which is due to severe hemorrhage resulting from a defect in vascular stabilization [6] . In contrast, S1P 2 and S1P 3 knockout mice are viable and exhibit only mild phenotypes [7] [8] [9] . In adult mice, S1P 1 , S1P 2 , and S1P 3 are known to be ubiquitously expressed, whereas S1P 4 and S1P 5 have been detected only in specific tissues [4, 7] . However, the expression of the receptors has not been well studied during embryonal stages.
Each S1P receptor specifically couples to certain G proteins. S1P 1 couples only with G i proteins [10, 11] , whereas S1P 2 and S1P 3 couple with G i , G q and G 12/13 [11] .
Although S1P 2 and S1P 3 couple with the same set of G proteins, their affinities differ. S1P 2 exhibits the highest affinity toward G 12/13 , whereas S1P 3 appears to primarily couple with G q , then G i [9, 12] . Reflecting their distinct preferences and affinities for specific G-proteins, S1P 1 , S1P 2 , and S1P 3 can induce different, sometimes opposite, cellular responses. For example, S1P 1 and S1P 3 stimulation by S1P induces cell 4 migration, but S1P 2 stimulation inhibits it [12] [13] [14] . Thus, regulating the expression of S1P receptors to provide a cellular balance may determine the effect of S1P on cellular processes.
Differentiation during embryogenesis is accompanied by dynamic changes in protein expression that promote cell and tissue-specific development. To date, information regarding the expression of S1P receptors during embryogenesis is limited.
Changes in S1P 1 expression during mouse embryonic development have been observed in the embryo proper and in two extra-embryonic tissues (the allantois and the yolk sac) [15] . S1P 1 expression patterns during mice embryogenesis have also been examined [6] .
In the present study we performed Northern blot analyses in mouse embryonal tissues and found that S1P 1 , S1P 2 , and S1P 3 mRNA expression is developmentally regulated. In addition, we examined the expression and regulation of these receptors using an F9 in vitro differentiation model. F9 embryonal carcinoma (EC) cells are a well-known system for extra-endoderm differentiation in early mouse embryogenesis. In the presence of retinoic acid (RA), F9 EC cells differentiate toward primitive endoderm (PrE) [16] , and if dibutyryl cyclic AMP (bt 2 cAMP) is added together with the RA, the F9 EC cells differentiate to parietal endoderm (PE) via PrE [17] . We examined the expression profile for each S1P receptor throughout this differentiation. Little S1P 1 is expressed in F9 EC cells, but expression is induced during PrE differentiation. This expression is in direct contrast to S1P 2 expression, which is down-regulated during the EC-to-PE (via PrE) differentiation [18] . The other S1P receptors are not detectable at either stage. Thus, the expression profile of the S1P receptors is altered during 5 differentiation. We also report here that S1P 1 small interference RNA (siRNA) inhibited PrE differentiation, suggesting that the induction of S1P 1 is required for this differentiation.
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Materials and methods
Cell culture and transfection. Mouse F9 cells were grown on 0.1% gelatin-coated dishes in Dulbecco's modified Eagle's medium (Sigma, St. Louis, MO; D6429) containing 10% fetal bovine serum and supplemented with 100 units/ml penicillin and 100 µg/ml streptomycin. For differentiation experiments, 1 µM all-trans-RA (Sigma) with or without 250 µM bt 2 cAMP (Sigma) was added to the medium. Transfections were performed using Lipofectamine TM 2000 reagent (Invitrogen, Carlsbad, CA).
Plasmids. The pCE-puro plasmid, a mammalian expression vector, contains a puromycin-resistant gene used for selecting stable transformants [19] . The pCE-puro 3xFLAG-4 plasmid is a derivative of the pCE-puro plasmid and was designed to produce a C-terminal triple FLAG (3xFLAG)-tagged protein. The pCE-puro S1P 1 -3xFLAG and pCE-puro S1P 2 -3xFLAG plasmids encoding S1P 1 -3xFLAG and S1P 2 -3xFLAG, respectively, were constructed by cloning S1P 1 or S1P 2 into the pCE-puro 3xFLAG-4 plasmid.
Preparing stable transformants of F9 cells. F9 derivatives that stably express S1P 1 -3xFLAG (F9-18 and F9-19) or S1P 2 -3xFLAG (F9-14 and F9-15) were prepared by transfection of the pCE-puro S1P 1 -3xFLAG or pCE-puro S1P 2 -3xFLAG plasmid, respectively, into F9 cells and by subsequent puromycin selection at 0.5 µg/ml for 1 week. F9-17 cells are control cells that were generated by transfection of pCE-puro 3xFLAG-4 vector and subsequent puromycin-selection. 32 P-labeled probes were prepared from cDNA for each S1P receptor, which had been amplified using specific primers (for S1P 1 , Hybridization of the probes to the mRNA blots was carried out in ExpressHyb Hybridization Solution (BD Biosciences Clontech, Palo Alto, CA) at 68˚C for 2 h.
Northern blot analysis and reverse transcription (RT)-PCR.
Radioactivities were quantified using a Bio-Imaging Analyzer BAS2500 (Fuji Photo Film, Tokyo, Japan).
RT-PCR was performed using total RNAs prepared from untreated or Phalloidin staining. Phalloidin staining of F-actin was performed on F9 EC, PrE, and PE cells as described previously using a fluorescence microscopy AxioSkop 2 plus (Carl Zeiss, Oberkochen, Germany) [19] . and scrambled S1P 1 siRNA, 5'-AATTGATGATCGTTCCGGACT-3'. F9 cells were 10 transfected with the appropriate siRNA together with the pCE-puro vector, which carries a puromycin resistant gene. Sixteen h after transfection on day 0, 1 µM RA and 0.5 µg/ml puromycin were added to the culture medium to initiate differentiation and to kill the untransfected cells, respectively. Medium was changed every 2 days, and puromycin was used for 48 h. Cells were recovered on days 0 through 4, and total cell lysates were prepared. Dab2 and actin were detected in the cell lysates by immunoblotting. Total RNA was prepared from cells on day 1 (40 h after transfection), and subjected to RT-PCR as described above.
Results
Regulation of S1P 1 , S1P 2 , and S1P 3 expresssion during embryonal development S1P 1 , S1P 2 , and S1P 3 are expressed ubiquitously among tissues in adult mice [7] .
However, their developmental stage-specific expression patterns have not been studied in depth. Therefore, we performed Northern blot analyses using a mouse embryo full stage blot. As shown in Fig. 1 , S1P 1 mRNA is abundantly expressed throughout mouse embryogenesis with a transient peak around embryonic day (E) 8.5. The expression of S1P 2 mRNA is high in earlier developmental stages but low in later stages. The highest S1P 2 mRNA expression was observed at E7.5; the expression gradually decreased toward E18.5. Conversely, the S1P 3 mRNA is low in earlier developmental stages (E4.5 to E9.5) but rapidly increase at E10.5, reaching a maximal level at E11.5. The expression then gradually decreases. These results indicate that S1P 1 , S1P 2 , and S1P 3 each exhibits a characteristic, developmental stage-specific expression pattern.
Induction of S1P 1 during PrE differentiation of F9 cells
Having determined that the expression of S1P receptors changes during development, we set out to explore the molecular mechanisms responsible. However, a whole animal model is not suitable for such analysis. Therefore, we used F9 cells, a well-known model system for extra-endoderm differentiation in early mouse embryogenesis. Reportedly, S1P 2 mRNA is gradually down-regulated during the EC-to-PE (via PrE) differentiation of F9 cells [18] . However, in that study expression of the other S1P receptors was not examined. We prepared total RNA from F9 cells treated with RA alone or with RA/bt 2 cAMP for 0, 3, or 6 days, and performed Northern blot analyses using specific probes for each S1P receptor. Untreated, F9 EC cells expressed a significant amount of S1P 2 mRNA (Fig. 3) . As reported [18] , the S1P 2 mRNA levels decreased by day 3 of treatment with RA/bt 2 cAMP, and were further decreased at day 6 (Fig. 3) . Treatment with RA alone did not cause a reduction in S1P 2 at day 3, but the levels were slightly decreased by day 6. In contrast, S1P 1 mRNA was barely detected in F9 EC cells, however its expression was induced by a 3 day treatment with RA or with RA/bt 2 cAMP (Fig. 3) . Overall, the S1P 1 levels were higher in the presence of bt 2 cAMP than in its absence, but the expression decreased in cells treated for 6 days with either treatment (Fig. 3) . These results indicate that S1P 1 mRNA is induced during EC-to-PrE differentiation. No S1P 3 , S1P 4 , or S1P 5 mRNA was detected at any differentiation stage (Fig. 3) .
We further investigated the S1P 1 mRNA induction over time. When F9 EC cells were treated with RA alone, the S1P 1 mRNA levels gradually increased, reaching 13 maximum at day 3 (Fig. 4A) . Maximum expression was maintained through day 5, but the levels slightly decreased at day 6. Thus, S1P 1 was induced during the EC-to-PrE differentiation. Treatment with RA/bt 2 cAMP induced more S1P 1 mRNA expression than treatment with RA alone did, however, after reaching maximum level at day 3, the S1P 1 levels gradually decreased (Fig. 4A) . These results suggest that in the course of successive differentiation from EC-to-PrE-to-PE, S1P 1 mRNA transiently peaks at the PrE stage.
Consistent with the previous report [18] , during treatment with RA/bt 2 cAMP S1P 2 mRNA levels slightly increased at day 1 then gradually decreased, reaching minimal levels at day 4 ( Fig. 4B) . In contrast, RA treatment caused a large increase at day 1, followed by only a slight decrease. At days 3 and 4, around which PrE differentiation was complete, the S1P 2 levels were equivalent to those observed in the untreated EC cells. These results indicate that S1P 2 levels are high at the EC and PrE stages but are nearly absent at the PE stage. Thus, S1P may function only through S1P 1 at the PE stage in contrast to the EC stage, at which S1P 2 is predominant.
Requirement of S1P 1 in the PrE differentiation
To investigate whether S1P 1 or S1P 2 is involved in the differentiation of EC cells into PrE cells, we prepared siRNAs specific to each of their sequences, as well as S1P 1 scrambled siRNA. RT-PCR using total RNAs prepared from F9 cells transfected with the S1P 1 , S1P 2 , or the scrambled siRNA confirmed a reduction in the S1P 1 and S1P 2 mRNAs by their specific siRNAs (Fig. 5A ). F9 cells were transfected with each of these siRNAs and treated with RA to induce PrE differentiation. Differentiation to PrE was monitored by investigating the expression of the PrE marker Dab2 [20] . As shown in transfected with the S1P 2 siRNA, indicating that it had no effect. However, the S1P 1 siRNA significantly inhibited the induction of Dab2 expression. Further RT-PCR analysis revealed that similar induction of two other PrE markers, the transcription factors GATA-4 [21] and GATA-6 [22] , was also reduced by the S1P 1 siRNA but not by the S1P 2 siRNA (Fig. 5C ). These results suggest that the induction of S1P 1 is required for the progression of PrE differentiation.
Overexpression of S1P 1 has no effect on PrE differentiation of F9 cells
We next examined whether overexpression of S1P 1 in F9 EC cells could stimulate PrE differentiation. Two independent F9 cells stably expressing S1P 1 -3xFLAG or S1P 2 -3xFLAG were incubated with RA/bt 2 cAMP, and the expression of Dab2 was examined. As shown in Fig. 6 , neither overexpression of S1P 1 -3xFLAG nor that of S1P 2 -3xFLAG stimulated PrE differentiation. Thus, S1P 1 expression is necessary but not sufficient for the PrE differentiation.
Discussion
In the present study, we have demonstrated that S1P 1 , S1P 2 , and S1P 3 mRNA each exhibit a characteristic, developmental stage-specific expression pattern. S1P 1 mRNA transiently increases around E8.5, soon after the beginning of vasculogenesis.
Vasculogenesis is initiated by the birth of angioblasts (endothelial cell precursors), followed by angioblast aggregation in extraembryonic regions. High levels S1P 1 expression have been observed in dorsal aorta, intersomitic arteries, and capillaries at E9.5 [6] . Thus, the high expression of S1P 1 at E8.5 and E9.5 may be related to the active vasculogenesis.
Although S1P 1 is the most important S1P receptor in the development of a stable and mature vascular system, S1P 2 and S1P 3 also function coordinately. S1P 1 -null mice appeared normal up to E11.5, but bleeding was evident at E12.5 [6] . Wide-spread hemorrhage and severe edema were observed at E13.5, and the mice could not survive beyond E14.5 [6] . Although both S1P 2 -and S1P 3 -null mice developed normally vascular systems, S1P 1 S1P 2 double knockout mice and S1P 1 S1P 2 S1P 3 triple knockout mice exhibited more severe vascular defects than those of the S1P 1 single knockout mice [23] . About half of the triple null mice exhibited bleeding at E10.5, and most of those died at E11.5. This timing coincides with a rapid induction of S1P 3 at E10.5 ( Fig.   1 ), suggesting that S1P 3 has some function in the development of vascular system around these embryonic stages.
We have also demonstrated here that the expression patterns of S1P 1 and S1P 2 mRNAs change during the differentiation of F9 cells, with EC expressing little S1P 1 and high levels of S1P 2 ; PrE, high levels of S1P 1 and high levels of S1P 2 ; and PE, intermediate levels of S1P 1 and little S1P 2 (Figs 3 and 4) . In addition, analysis using siRNA revealed that S1P 1 expression is required for PrE differentiation (Fig. 5) .
Considering that PrE cells contain a high amount of S1P 2 , S1P 1 might have an important function in PrE differentiation that is not substituted for by S1P 2 . Such differences in function are well established in regards to cell migration [12] [13] [14] .
Differentiation is a complicated process, in which many transcriptional factors, and thus many genes, are temporally regulated. During F9 differentiation, the most immediate gene response is likely mediated by RA receptors bound to RA. Two classes of such receptors are known, retinoic acid receptors (RARs) and retinoid X receptors (RXRs), each of which has three isotypes (α, β, and γ). These receptors form homodimers or heterodimers and activate the transcription of genes containing the retinoic acid response element (RARE). The RXRα/RARγ heterodimer has been shown to be important for the PrE and PE differentiation of F9 cells [24] .
Genes exhibiting changes in their levels during RA-mediated PrE differentiation are classified mainly into two groups, those whose expression changes within the first 24 h and those peaking around day 3 [25, 26] . The first group includes genes directly activated by RA, but also those activated indirectly. Several transcriptional factors, including AP-1, GATA-4, and GATA-6, are induced around day 3 [21, [27] [28] [29] and may be involved in the expression of genes in the second group. We found that S1P 1 mRNA expression reaches maximum at day 3, whereas S1P 2 mRNA transiently increases on day 1. These results suggest that S1P 1 and S1P 2 belong to the second and first groups, respectively, although the transcription factors involved in their increases are presently unknown. Using the transcription factor database TRANSFAC and accompanying programs (http://transfac.gbf.de/TRANSFAC), we found two putative AP-1 binding sites in the S1P 1 promoter region. Thus, it is possible that AP-1 is responsible for the induction of S1P 1 during EC-to-PrE differentiation.
S1P is abundant in blood [30] and, therefore, in extracellular spaces. However, S1P also exists intracellularly in most cells, although the levels are quite low.
Intracellular S1P is proposed to function as a second messenger of various stimuli such as growth factors and cytokines [31] . We recently reported that sphingosine kinase and S1P lyase, both of which are involved in S1P metabolism, were up-regulated during F9
PrE differentiation [19] . Moreover, S1P accumulation, resulting from the disruption of the S1P lyase gene or the overproduction of sphingosine kinase, resulted in accelerated of the PrE differentiation [19] , suggesting that intracellular S1P is also involved in this process. Thus, it appears that extracellular and intracellular S1P cooperatively regulate PrE differentiation.
Expression of S1P 1 is known to be altered during several types of development and differentiation stages. For example, in human endothelial cells the expression of S1P 1 was rapidly increased by treatment with phorbol 12-myristate 13-acetate, which induces differentiation of these cells into capillary-like, tubular structures [32] . Changes in S1P 1 expression during embryonic development has also been shown in the embryo
proper and in two extra-embryonic tissues (the allantois and the yolk sac) [15] .
Treatment of endothelial cells with vascular endothelial growth factor (VEGF) rapidly 18 induces expression of S1P 1 , which is attenuated by the tyrosine kinase inhibitor genistein and by the protein kinase C inhibitor calphostin C [33] . Moreover, S1P 1 levels change during T cell maturation and activation. In the course of T cell maturation in the thymus, S1P 1 is strongly upregulated [34, 35] . Later, when mature naïve T cells encounter their specific antigens in the lymph node, S1P 1 is downregulated to prevent S1P gradient-induced exit from the lymph node [34] . After activation and clonal expansion, T cells restore their S1P 1 levels and exit [34] . The molecular mechanism regulating such S1P 1 expression is unclear, however, and further analysis is needed. For this purpose, the well-examined F9 system will be useful. Total RNA was prepared from each culture and equivalent amounts (20 µg) were subjected to Northern blotting using a 32 P-labeled probe for S1P 1 (A) or S1P 2 (B).
Figure legends
Radioactivities associated with the S1P 1 and S1P 2 mRNAs were quantified using a Bio-Imaging Analyzer BAS2500. Values are illustrated relative to the amount of the S1P 1 mRNA at day 1 or the S1P 2 mRNA at day 0, and represent the mean ± SD from three independent experiments. . Forced expression of S1P 1 or S1P 2 has no effect on PrE differentiation. F9 cells stably expressing vector only (F9-17), S1P 1 -3xFLAG (F9-18 and F9-19), or S1P 2 -3xFLAG (F9-14 and F9-15) were incubated with 1 µM RA and 250 µM bt 2 cAMP for the indicated times. Total proteins (15 µg) were separated by SDS-PAGE, followed by immunoblotting with an anti-Dab2 or anti-actin antibody.
